Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT? (Q53209171)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 August 2011

Language	Label	Description	Also known as
English	Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?	scientific article published on 7 August 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT? (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

1 reference

based on heuristic

inferred from title

iodine in medicine

1 reference

based on heuristic

inferred from title

U Joseph Schoepf

6

object named as

U J Schoepf

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

Stefan O. Schoenberg

11

object named as

S O Schoenberg

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

2

object named as

Thomas Henzler

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

author name string

G Schmid-Bindert

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

T Q Chu

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

M Meyer

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

J W Nance

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

D J Dinter

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

P Apfaltrer

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

R Krissak

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

C Manegold

10

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

C Fink

12

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

language of work or name

0 references

publication date

7 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

European Radiology

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

22

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

93-103

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the Europ

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Value of whole-body FDG PET in management of lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Prognostic value of [18F]FDG-PET imaging in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

FDG-PET in the Locoregional Lymph Node Staging of Non-small Cell Lung Cancer A Comprehensive Review of the Leuven Lung Cancer Group Experience

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Material differentiation by dual energy CT: initial experience

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Assessment of lobar perfusion in smokers according to the presence and severity of emphysema: preliminary experience with dual-energy CT angiography.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodules: initial experience

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Tumor response evaluation in oncology: current update.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesions.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Imaging angiogenesis.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Is 18F-FDG PET/CT useful for the early prediction of histopathologic response to neoadjuvant erlotinib in patients with non-small cell lung cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2230-3

21 January 2018

Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT

1 reference

https://pubmed.ncbi.nlm.nih.gov/21822784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21822784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21822784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Solitary pulmonary nodules: association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21822784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material

1 reference

https://pubmed.ncbi.nlm.nih.gov/21822784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21822784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Solitary pulmonary nodule: preliminary study of evaluation with incremental dynamic CT

1 reference

https://pubmed.ncbi.nlm.nih.gov/21822784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional CT: lung nodule evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21822784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Solitary pulmonary nodule: CT evaluation of enhancement with iodinated contrast material--a preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/21822784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00330-011-2230-3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21822784

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53209171&oldid=2212030944"